786 Statin therapy is associated with lower mortality among patients with ischemic heart failure. Date from one center study

Stawicki, S.; Roik, M.; Kosior, D.A.; Starczewska, M.H.; Tomik, Z.; Warszawik, O.; Opolski, G.
June 2006
European Journal of Heart Failure. Supplements;Jun2006, Vol. 5 Issue 1, p189
Academic Journal
An abstract of the study "Statin Therapy Is Associated With Lower Mortality Among Patients With Ischemic Heart Failure. Date From One Center Study," by S. Stawicki et al. is presented.


Related Articles

  • 784 Is initiation or continuation of statin therapy following diagnosis of heart failure associated with lower all-cause mortality in patients with coronary artery disease? Loh, P.H.; Windram, J.; Tin, L.; Reddy, P.; Rigby, A.S.; Nikitin, N.P.; Clark, A.L.; Cleland, J.G.F. // European Journal of Heart Failure. Supplements;Jun2006, Vol. 5 Issue 1, p188 

    An abstract of the study "Is Initiation or Continuation of Statin Therapy Following Diagnosis of Heart Failure Associated With Lower All-Cause Mortality in Patients With Coronary Artery Disease?" by P. H. Loh et al is presented.

  • 724 Low doses of statins improve neurohumoral activity in patients with moderate-to-severe congestive heart failure due to coronary artery disease. Berezin, A. // European Journal of Heart Failure. Supplements;Jun2006, Vol. 5 Issue 1, p168 

    An abstract of the study "Low Doses of Statins Improve Neurohumoral Activity in Patients With Moderate-to-Severe Congestive Heart Failure Due to Coronary Artery Disease," by A. Berezin is presented.

  • 747 Effects of statins in pulmonary hypertension in patients with severe chronic heart failure. Rylova, A.; Rylova, N.; Arutyunov, G. // European Journal of Heart Failure. Supplements;Jun2006, Vol. 5 Issue 1, p176 

    An abstract of the study "Effects of Statins in Pulmonary Hypertension in Patients With Severe Chronic Heart Failure," by A. Rylova et al. is presented.

  • COPD exacerbations: the heart of the matter.  // Thorax;Dec2013 Supplement, Vol. 68 Issue S3, pA133 

    The article presents abstracts on topics related to chronic obstructive pulmonary disease (COPD) exacerbations including Statin therapy's cardiovascular effect on artery stiffness in COPD patients, the skeletal muscle weakness in COPD, and left ventricular hypertrophy's impact on COPD's mortality.

  • Pulmonary infection: clinical studies.  // Thorax;Dec2013 Supplement, Vol. 68 Issue S3, p463 

    The article presents abstracts on clinical studies of pulmonary infection including use of statin associated with community acquired pneumonia, impact of vitamin D supplementation on respiratory system and validation of Bronchiectasis severity index.

  • Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Muchova, Lucie; Wong, Ronald J.; Hsu, Mark; Morioka, Ichiro; Vitek, Libor; Zelenka, Jaroslav; Schröder, Henning; Stevenson, David K. // Canadian Journal of Physiology & Pharmacology;Aug2007, Vol. 85 Issue 8, p800 

    Heme oxygenase (HO) has a central role in cellular antioxidant defences and vascular protection, and it may mediate pleiotropic actions of drugs used in cardiovascular therapy. We investigated whether long-term use of statins upregulates HO activity and increases carbon monoxide (CO) and...

  • Citations and Clinicians' Notes: Miscellaneous.  // Current Medical Literature: Respiratory Medicine;2003, Vol. 17 Issue 4, p117 

    Presents several abstracts from citations and clinicians' notes on respiratory medicine. "C-reactive protein levels correlate with mortality and organ failure in critically ill patients," by Lobo S.M., Lobo F.R., Bota D.P., Lopes-Ferreira F., Soliman H.M., Melot C., and Vincent J.L.;...

  • Lipid Lowering for Secondary Prevention of Cardiovascular Disease in Older Adults. Thomas, Joseph E.; Tershakovec, Andrew M.; Jones-Burton, Charlotte; Sayeed, Reza A.; Foody, JoAnne M. // Drugs & Aging;2010, Vol. 27 Issue 12, p959 

    A perceived lack of evidence for benefit and safety concerns may lead to underprescription of HMG-CoA reductase inhibitors (statins) in older adults. This article reviews clinical data regarding the effect of lipid-lowering therapies on cardiovascular outcomes in older adults with a focus on...

  • Low risk adults benefit from statins too.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/26/2012, Vol. 344 Issue 7858, p12 

    The article discuses a meta-analysis which notes that the benefit obtained from statin treatment by adults at low risk of cardiovascular disease and those above the thresholds are the same.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics